Free Trial

Iradimed (IRMD) SEC Filings & 10K Form

Iradimed logo
$54.65 +1.30 (+2.44%)
(As of 12/20/2024 05:16 PM ET)

Recent Iradimed SEC Filings

DateFilerForm TypeView
12/10/2024
8:00 PM
ALLEN MONTY K (Reporting)
Iradimed (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2024
8:00 PM
Iradimed (Issuer)
VUOTO ANTHONY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2024
8:00 PM
Iradimed (Issuer)
Scharen-Guivel Hilda Frederique (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2024
8:00 PM
HAWKINS JAMES B (Reporting)
Iradimed (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/06/2024
2:42 PM
Chiprin Jeff (Reporting)
Iradimed (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
12/02/2024
8:00 PM
GLENN JOHN (Reporting)
Iradimed (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/06/2024
11:14 AM
Iradimed (Subject)
VUOTO ANTHONY (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/31/2024
3:15 PM
Iradimed (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/31/2024
7:00 AM
Iradimed (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/22/2024
2:24 PM
BlackRock, Inc. (Filed by)
Iradimed (Subject)
Form SC 13G
10/15/2024
4:45 PM
Iradimed (Issuer)
Scharen-Guivel Hilda Frederique (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/01/2024
3:30 PM
Iradimed (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/01/2024
7:30 AM
Iradimed (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/07/2024
7:30 AM
Iradimed (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/04/2024
4:15 PM
ALLEN MONTY K (Reporting)
Iradimed (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2024
9:40 AM
ALLEN MONTY K (Reporting)
Iradimed (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/03/2024
7:30 AM
Iradimed (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2024
8:16 AM
Iradimed (Filer)
Form ARS
05/08/2024
11:15 PM
Iradimed (Filer)
Form EFFECT
05/02/2024
7:30 AM
Iradimed (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/01/2024
7:30 AM
Iradimed (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/12/2024
11:03 AM
Iradimed (Subject)
Nine Ten Capital Management LLC (Filed by)
Form SC 13G/A
02/08/2024
7:05 AM
Iradimed (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/02/2024
8:44 AM
Iradimed (Subject)
Soleus Capital Master Fund, L.P. (Filed by)
Form SC 13G/A
12/27/2023
5:30 PM
Iradimed (Issuer)
Susi Roger E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/22/2023
4:15 PM
Iradimed (Issuer)
Susi Roger E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:IRMD) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners